print

Country Report

Dermatologicals in Japan

| Pages: 53

Price: US$900

About this Report

Executive Summary

TRENDS

  • Value sales of dermatologicals increased by 1% in Japan during 2012. Double-digit growth was observed in vaginal antifungals and cold sore treatments, which resulted in positive overall growth in dermatologicals. However, hair loss treatments—the largest dermatologicals category in Japan—suffered a 2% value decline in 2012 and this had a negative impact on the entire category of dermatologicals.

COMPETITIVE LANDSCAPE

  • Dermatologicals in Japan is a highly fragmented category and apart from the leading player Taisho Pharmaceutical, no company was able to establish a value share in excess of 10% during 2012. Medicated skin care is a category which is dominated by Japanese manufacturers and there were no international players among the top 10 during 2012. Price competition in dermatologicals remains at a low level and sales of private label dermatologicals remained negligible in 2012, although one exception was topical germicidals/antiseptics, a category in which private label is beginning to establish a presence.

PROSPECTS

  • Topical dermatologicals is expected to increase in constant value at a CAGR of 1% over the forecast period. The major contributor to this growth is expected to be cold sore treatments, which is expected to increase in constant value at a CAGR of 12% over the forecast period. This high growth is set to be due to the relatively low development of cold sore treatments and the small base from which the category is rising, with value sales of just ¥2.8 billion in 2012. As herpes is a condition which results in recurring cold sores, continuous demand is expected from the loyal users of the category’s leading brands. Antiparasitics/lice (head and body) treatments is expected to record a continuous constant value decline over the course of the forecast period. As increasing numbers of Japanese consumers pay greater attention to their personal hygiene and engage in daily cleansing routines for their skin, the number of Japanese people suffering from parasites is declining and demand for antiparasitics/lice (head and body) treatments is consequently expected to fall.

Samples (FAQs about samples):

doc_pdf.png Sample Medicated Skin Care Market Research Report

doc_excel_table.png Sample Medicated Skin Care Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Japan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Japan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Japan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Japan?
  • What are the major brands in Japan?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Dermatologicals in Japan - Category Analysis

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

CATEGORY DATA

  • Table 1 Sales of Dermatologicals by Category: Value 2007-2012
  • Table 2 Sales of Dermatologicals by Category: % Value Growth 2007-2012
  • Table 3 Dermatologicals Company Shares by Value 2008-2012
  • Table 4 Dermatologicals Brand Shares by Value 2009-2012
  • Table 5 Hair Loss Treatments Brand Shares by Value 2009-2012
  • Table 6 Forecast Sales of Dermatologicals by Category: Value 2012-2017
  • Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2012-2017

Dermatologicals in Japan - Company Profiles

Daiichi Sankyo Healthcare Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 1 Daiichi Sankyo Healthcare Co Ltd: Key Facts
  • Summary 2 Daiichi Sankyo Healthcare Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2012

Hisamitsu Pharmaceutical Co Inc in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 4 Hisamitsu Pharmaceutical Co Inc: Key Facts
  • Summary 5 Hisamitsu Pharmaceutical Co Inc: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2012

Kobayashi Pharmaceutical Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 7 Kobayashi Pharmaceutical Co Ltd: Key Facts
  • Summary 8 Kobayashi Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Kobayashi Pharmaceutical Co Ltd: Competitive Position 2012

Nichiban Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 10 Nichiban Co Ltd: Key Facts
  • Summary 11 Nichiban Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Nichiban Co Ltd: Competitive Position 2012

Otsuka Pharmaceutical Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 13 Otsuka Pharmaceutical Co Ltd: Key Facts
  • Summary 14 Otsuka Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 15 Otsuka Pharmaceutical Co Ltd: Competitive Position 2012

Rohto Pharmaceutical Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 16 Rohto Pharmaceutical Co Ltd: Key Facts
  • Summary 17 Rohto Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 18 Rohto Pharmaceutical Co Ltd: Competitive Position 2012

Sato Pharmaceutical Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 19 Sato Pharmaceutical Co Ltd: Key Facts
  • Summary 20 Sato Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 21 Sato Pharmaceutical Co Ltd: Competitive Position 2012

Taisho Pharmaceutical Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 22 Taisho Pharmaceutical Co Ltd: Key Facts
  • Summary 23 Taisho Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 24 Taisho Pharmaceutical Co Ltd: Competitive Position 2012

Takeda Pharmaceutical Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 25 Takeda Pharmaceutical Co Ltd: Key Facts
  • Summary 26 Takeda Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 27 Takeda Pharmaceutical Co Ltd: Competitive Position 2012

Consumer Health in Japan - Industry Context

EXECUTIVE SUMMARY

Consumer health declines slightly in value sales

Moderate level of pollen discourages sales of antihistamines/allergy remedies

Taisho Pharmaceutical Co Ltd maintains the leading position

Online sales of OTC medication becomes legal

Value sales of OTC medication is expected to see a slight decline

KEY TRENDS AND DEVELOPMENTS

Online sales of OTC medication becomes legal

Demographic change negatively affects sales of OTC medication

Consumers look for flexible and value added services to retailers

Moderate level of pollen discourages sales of allergy remedies

Exercise and running continue to be popularity among consumers

MARKET INDICATORS

  • Table 8 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  • Table 9 Life Expectancy at Birth 2007-2012

MARKET DATA

  • Table 10 Sales of Consumer Health by Category: Value 2007-2012
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2007-2012
  • Table 12 Consumer Health Company Shares 2008-2012
  • Table 13 Consumer Health Brand Shares 2009-2012
  • Table 14 Penetration of Private Label by Category 2007-2012
  • Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  • Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  • Table 17 Forecast Sales of Consumer Health by Category: Value 2012-2017
  • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017

APPENDIX

OTC registration and classification

Consumer health registration

Consumer health advertising

Consumer health packaging

Consumer health Distribution

Regulation of Japanese traditional herbal remedies (kampo)

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 28 OTC: Switches 2010-2012

DEFINITIONS

SOURCES

  • Summary 29 Research Sources

Segmentation

This market research report includes the following:

  • Dermatologicals
    • Medicated Shampoos
    • Topical Antifungals
    • Vaginal Antifungals
    • Hair Loss Treatments
    • Nappy (Diaper) Rash Treatments
    • Antiparasitics/Lice (Head and Body) Treatments
    • Antipruritics
    • Paediatric Dermatologicals
    • Cold Sore Treatments
    • Haemorrhoid Treatments
    • Topical Allergy Remedies/Antihistamines
    • Topical Germicidals/Antiseptics

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

print

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!